WASHINGTON, June 5, 2023 (AFP) – A treatment that involves genetically modifying the body’s own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type of blood cancer, results showed Monday. Ciltacabtagene autoleucel — also known by its trade name Carvykti — was tested in a clinical trial involving 419 patients with multiple myeloma, whose disease was not responsive to the current frontline drug […]